Gilead’s layoffs include 72 employees at its Seattle location, which will close. Kite will shut down its Philadelphia ...

Fintel reports that on November 14, 2024, Citigroup initiated coverage of Gilead Sciences (NasdaqGS:GILD) with a Buy ...

The Washington State Employment Security Department said in the filing that 72 employees will be laid off on Jan. 17. A ...

More cuts are hitting Gilead’s cell therapy wing, including the closure of a Philadelphia office. A small number of ...

There was a heated Board of Supervisors meeting in San Mateo County as the board unanimously voted to ask Sheriff Christina Corpus to step down.

Roughly a year ago, Gilead Sciences revealed that it was laying off about 7% of Kite Pharma’s workforce in a bid to refresh ...

Data shows Latino and Black people make up nearly 30% of the Bay Area population but only about 10% of active medical ...

Watch video of Massillon football's Mateo Herrera kicking a 36-yard field goal against McKinley as time expired in the first half News Sports Entertainment Lifestyle Opinion Advertise Obituaries ...

Please verify your email address. Despite its age, Grand Theft Auto: San Andreas had one immersive feature that Rockstar games have since omitted, and GTA 6 should change that. They may seem ...

STAT+ subscribers can sign up here to get it delivered to their inbox. The next referendum on Gilead Sciences’ oft-criticized oncology business is approaching. Circle Nov. 5 on your calendars.

Gilead Sciences, Inc. (GILD), headquartered in Foster City, California, is a global biopharmaceutical leader known for its groundbreaking work in antiviral therapies. Valued at a market cap of $ ...

Analyst Terence Flynn from Morgan Stanley maintained a Hold rating on Gilead Sciences (GILD – Research Report) and keeping the price target at $84.00. Terence Flynn’s rating is based on ...